This analysis examines the historical and forecast performance for Shionogi in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sa

Somaxon Pharmaceuticals (Somaxon) is a development stage pharmaceutical company engaged in in-licensing and developing proprietary product candidates for the treatment of psychiatry and neurology disorders.

The Merger and Acquisition Agreements in Biopharma report provides comprehensive understanding and unprecedented access to the merger and acquisition (M&A) agreements entered into by the worlds leading biopharma companies

Analysis of Eli Lilly’s corporate strategy, marketed portfolio, pipeline potential and financial position in 2007 and to 2013

The number of blockbusters continues to increase. The number is set to increase to 112 in 2007. Of the products set to receive FDA approval this year and generate blockbuster status on an annual basis, GSK’s Cervarix, intended for the prevention

The GlaxoSmithKline Partnering Guide 2008 provides an in-depth insight into the dealmaking interests and activity of one of the worlds leading biopharma companies

Flamel Technologies SA: Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile

High impact company profile available at BioMarket

Illumina is one of the leading companies in genome and genotyping market. The company’s proprietary technology enables conversion of raw sequence data from the human genome into medically relevant information. The January 2007 acquisition of Sole

Introgen Therapeutics (Introgen) is a biopharmaceutical company focused on the discovery, development and commercialization of targeted molecular therapies for the treatment of cancer. The company has been successful in developing a strong portfolio of

Analysis of Schering-Plough’s corporate strategy, marketed portfolio, pipeline potential and financial position in 2007 and to 2013

The CSL Partnering Guide 2008 provides an in-depth insight into the dealmaking interests and activity of one of the worlds leading biopharma companies

Iomai Corporation: Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile

High impact company profile available at BioMarket

Danaher is a diversified technology company engaged in designing, manufacturing and marketing of professional, medical, industrial and consumer products with strong brand names and significant market positions.

This analysis examines the historical and forecast performance for Sepracor in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sa

The Actavis Pharma Partnering Guide 2008 provides an in-depth insight into the dealmaking interests and activity of one of the worlds leading biopharma companies

High impact company profile available at BioMarket

Orexigen Therapeutics Inc: Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile

High impact company profile available at BioMarket

This analysis examines the historical and forecast performance for Gilead in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sale

Stryker Corporation (Stryker) develops, manufactures and markets medical devices and instrumentations in the orthopedic as well the other medical surgical markets. While it is best known for its orthopedic products, it also has a material presence in c

This analysis examines the historical and forecast performance for Abbott in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sale

The Takeda Partnering Guide 2008 provides an in-depth insight into the dealmaking interests and activity of one of the worlds leading biopharma companies

Advanced Medical Optics Inc: Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile

High impact company profile available at BioMarket

The Medicines Company: Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile

High impact company profile available at BioMarket

CSL is a global, specialty biopharmaceutical company engaged in the research, development, manufacture and marketing of pharmaceutical products of biological origin such as vaccines and plasma protein biotherapies.

This analysis examines the historical and forecast performance for J&J in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales f